Transmissibility and transmission of respiratory viruses

Nancy H L Leung, Nancy H L Leung

Abstract

Human respiratory virus infections lead to a spectrum of respiratory symptoms and disease severity, contributing to substantial morbidity, mortality and economic losses worldwide, as seen in the COVID-19 pandemic. Belonging to diverse families, respiratory viruses differ in how easy they spread (transmissibility) and the mechanism (modes) of transmission. Transmissibility as estimated by the basic reproduction number (R0) or secondary attack rate is heterogeneous for the same virus. Respiratory viruses can be transmitted via four major modes of transmission: direct (physical) contact, indirect contact (fomite), (large) droplets and (fine) aerosols. We know little about the relative contribution of each mode to the transmission of a particular virus in different settings, and how its variation affects transmissibility and transmission dynamics. Discussion on the particle size threshold between droplets and aerosols and the importance of aerosol transmission for severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) and influenza virus is ongoing. Mechanistic evidence supports the efficacies of non-pharmaceutical interventions with regard to virus reduction; however, more data are needed on their effectiveness in reducing transmission. Understanding the relative contribution of different modes to transmission is crucial to inform the effectiveness of non-pharmaceutical interventions in the population. Intervening against multiple modes of transmission should be more effective than acting on a single mode.

Conflict of interest statement

The author declares no competing interests.

© 2021. Springer Nature Limited.

Figures

Fig. 1. Major modes of transmission of…
Fig. 1. Major modes of transmission of respiratory viruses during short-range and long-range transmission.
During an acute respiratory virus infection, an infected individual (infector; red) may shed virus in exhaled breath droplets and aerosols, and may also contaminate their immediate bodily surfaces (for example, skin and clothes) or surrounding objects and surfaces (for example, tables) with their respiratory secretions. In general, if a susceptible individual (infectee; grey) is close to the infector, short-range transmission may occur when the infectee breathes in the virus-laden droplets or aerosols released by the infector, during direct (physical) contact with the infector or during physical contact with objects or surfaces contaminated (fomite) by the infector. If the infectee is at a distance from the infector, long-range transmission may occur when the infectee breathes in the virus-laden aerosols released by the infector or during physical contact with a fomite. However, the terminology and the defining features of each mode of respiratory virus transmission, especially regarding redefining the particle size threshold between droplets and aerosols, is under active discussion (see the section Terminology and defining features of modes of transmission).
Fig. 2. Viral, environmental and host determinants…
Fig. 2. Viral, environmental and host determinants of respiratory virus transmission.
Virus, environmental and host factors influence whether a successful transmission occurs by governing the infectivity of the respiratory virus, the contagiousness of the infected person, the environmental stress on the virus, which affects its persistence and survival during transmission, and the susceptibility of the exposed person.

References

    1. James SL, et al. Global, regional, and national incidence, prevalence, and years lived with disability for 354 diseases and injuries for 195 countries and territories, 1990–2017: a systematic analysis for the Global Burden of Disease Study 2017. Lancet. 2018;392:1789–1858. doi: 10.1016/S0140-6736(18)32279-7.
    1. Roth GA, et al. Global, regional, and national age-sex-specific mortality for 282 causes of death in 195 countries and territories, 1980–2017: a systematic analysis for the Global Burden of Disease Study 2017. Lancet. 2018;392:1736–1788. doi: 10.1016/S0140-6736(18)32203-7.
    1. Fendrick AM, Monto AS, Nightengale B, Sarnes M. The economic burden of non-influenza-related viral respiratory tract infection in the United States. Arch. Intern. Med. 2003;163:487–494. doi: 10.1001/archinte.163.4.487.
    1. Belser JA, Maines TR, Tumpey TM, Katz JM. Influenza A virus transmission: contributing factors and clinical implications. Expert Rev. Mol. Med. 2010;12:e39. doi: 10.1017/S1462399410001705.
    1. Richard M, Fouchier RA. Influenza A virus transmission via respiratory aerosols or droplets as it relates to pandemic potential. FEMS Microbiol. Rev. 2015;40:68–85. doi: 10.1093/femsre/fuv039.
    1. Brankston G, Gitterman L, Hirji Z, Lemieux C, Gardam M. Transmission of influenza A in human beings. Lancet Infect. Dis. 2007;7:257–265. doi: 10.1016/S1473-3099(07)70029-4.
    1. Killingley B, Nguyen-Van-Tam J. Routes of influenza transmission. Influenza Other Respir. Viruses. 2013;7(Suppl. 2):42–51. doi: 10.1111/irv.12080.
    1. Killingley B, et al. Potential role of human challenge studies for investigation of influenza transmission. Lancet Infect. Dis. 2011;11:879–886. doi: 10.1016/S1473-3099(11)70142-6.
    1. Kutter JS, Spronken MI, Fraaij PL, Fouchier RAM, Herfst S. Transmission routes of respiratory viruses among humans. Curr. Opin. Virol. 2018;28:142–151. doi: 10.1016/j.coviro.2018.01.001.
    1. Tellier R. Aerosol transmission of influenza A virus: a review of new studies. J. R. Soc. Interface. 2009;6(Suppl. 6):S783–S790.
    1. Tang JW, Li Y, Eames I, Chan PK, Ridgway GL. Factors involved in the aerosol transmission of infection and control of ventilation in healthcare premises. J. Hosp. Infect. 2006;64:100–114. doi: 10.1016/j.jhin.2006.05.022.
    1. Tellier R, Li Y, Cowling BJ, Tang JW. Recognition of aerosol transmission of infectious agents: a commentary. BMC Infect. Dis. 2019;19:101. doi: 10.1186/s12879-019-3707-y.
    1. Marr LC, Tang JW, Van Mullekom J, Lakdawala SS. Mechanistic insights into the effect of humidity on airborne influenza virus survival, transmission and incidence. J. R. Soc. Interface. 2019;16:20180298. doi: 10.1098/rsif.2018.0298.
    1. Lemieux C, Brankston G, Gitterman L, Hirji Z, Gardam M. Questioning aerosol transmission of influenza. Emerg. Infect. Dis. 2007;13:173–174. doi: 10.3201/eid1301.061202.
    1. Shiu EYC, Leung NHL, Cowling BJ. Controversy around airborne versus droplet transmission of respiratory viruses: implication for infection prevention. Curr. Opin. Infect. Dis. 2019;32:372–379. doi: 10.1097/QCO.0000000000000563.
    1. MacIntyre CR, Chughtai AA. Facemasks for the prevention of infection in healthcare and community settings. BMJ. 2015;350:h694. doi: 10.1136/bmj.h694.
    1. Xiao J, et al. Nonpharmaceutical measures for pandemic influenza in nonhealthcare settings-personal protective and environmental measures. Emerg. Infect. Dis. 2020;26:967–975. doi: 10.3201/eid2605.190994.
    1. Jefferson, T. et al. Physical interventions to interrupt or reduce the spread of respiratory viruses. Cochrane Database Syst. Rev.10.1002/14651858.CD006207.pub5 (2020).
    1. Saunders-Hastings P, Crispo JAG, Sikora L, Krewski D. Effectiveness of personal protective measures in reducing pandemic influenza transmission: A systematic review and meta-analysis. Epidemics. 2017;20:1–20. doi: 10.1016/j.epidem.2017.04.003.
    1. Yen HL, et al. Hemagglutinin-neuraminidase balance confers respiratory-droplet transmissibility of the pandemic H1N1 influenza virus in ferrets. Proc. Natl Acad. Sci. USA. 2011;108:14264–14269. doi: 10.1073/pnas.1111000108.
    1. Herfst S, et al. Airborne transmission of influenza A/H5N1 virus between ferrets. Science. 2012;336:1534–1541. doi: 10.1126/science.1213362.
    1. Bouvier NM, Lowen AC, Palese P. Oseltamivir-resistant influenza A viruses are transmitted efficiently among guinea pigs by direct contact but not by aerosol. J. Virol. 2008;82:10052–10058. doi: 10.1128/JVI.01226-08.
    1. Zhou J, et al. Defining the sizes of airborne particles that mediate influenza transmission in ferrets. Proc. Natl Acad. Sci. USA. 2018;115:E2386–E2392. doi: 10.1073/pnas.1716771115.
    1. Richard M, et al. Influenza A viruses are transmitted via the air from the nasal respiratory epithelium of ferrets. Nat. Commun. 2020;11:766. doi: 10.1038/s41467-020-14626-0.
    1. Nguyen-Van-Tam JS, et al. Minimal transmission in an influenza A (H3N2) human challenge-transmission model within a controlled exposure environment. PLoS Pathog. 2020;16:e1008704. doi: 10.1371/journal.ppat.1008704.
    1. Yang Y, et al. The transmissibility and control of pandemic influenza A (H1N1) virus. Science. 2009;326:729–733. doi: 10.1126/science.1177373.
    1. Liu Y, Eggo RM, Kucharski AJ. Secondary attack rate and superspreading events for SARS-CoV-2. Lancet. 2020;395:e47. doi: 10.1016/S0140-6736(20)30462-1.
    1. Siegel JD, Rhinehart E, Jackson M, Chiarello L. 2007 guideline for isolation precautions: preventing transmission of infectious agents in health care settings. Am. J. Infect. Control. 2007;35:S65–S164. doi: 10.1016/j.ajic.2007.10.007.
    1. Xiao F, et al. Evidence for gastrointestinal infection of SARS-CoV-2. Gastroenterology. 2020;158:1831–1833 e3. doi: 10.1053/j.gastro.2020.02.055.
    1. Minodier L, et al. Clinical and virological factors associated with gastrointestinal symptoms in patients with acute respiratory infection: a two-year prospective study in general practice medicine. BMC Infect. Dis. 2017;17:729. doi: 10.1186/s12879-017-2823-9.
    1. Johnson D, Lynch R, Marshall C, Mead K, Hirst D. Aerosol generation by modern flush toilets. Aerosol Sci. Technol. 2013;47:1047–1057. doi: 10.1080/02786826.2013.814911.
    1. Colavita F, et al. SARS-CoV-2 isolation from ocular secretions of a patient with COVID-19 in Italy with prolonged viral RNA detection. Ann. Intern. Med. 2020 doi: 10.7326/M20-1176.
    1. Bischoff WE, Reid T, Russell GB, Peters TR. Transocular entry of seasonal influenza-attenuated virus aerosols and the efficacy of N95 respirators, surgical masks, and eye protection in humans. J. Infect. Dis. 2011;204:193–199. doi: 10.1093/infdis/jir238.
    1. Milton DK. A rosetta stone for understanding infectious drops and aerosols. J. Pediatric Infect. Dis. Soc. 2020;9:413–415. doi: 10.1093/jpids/piaa079.
    1. U.S. Department of Health and Human Services, Centers for Disease Control and Prevention. Guidelines for environmental infection control in health-care facilities. Recommendations of CDC and the Healthcare Infection Control Practices Advisory Committee (HICPAC). (2003).
    1. Lei H, et al. Routes of transmission of influenza A H1N1, SARS CoV, and norovirus in air cabin: comparative analyses. Indoor Air. 2018;28:394–403. doi: 10.1111/ina.12445.
    1. British Columbia Centre for Disease Control. About COVID-19: How it Spreads. (2020).
    1. World Health Organization. Modes of transmission of virus causing COVID-19: implications for IPC precaution recommendations: scientific brief, 27 March 2020. (2020).
    1. World Health Organization. Transmission of SARS-CoV-2: implications for infection prevention precautions: scientific brief, 9 July 2020. (2020).
    1. Zhang N, et al. Close contact behavior in indoor environment and transmission of respiratory infection. Indoor Air. 2020;30:645–661. doi: 10.1111/ina.12673.
    1. Li Y, et al. Role of ventilation in airborne transmission of infectious agents in the built environment - a multidisciplinary systematic review. Indoor Air. 2007;17:2–18. doi: 10.1111/j.1600-0668.2006.00445.x.
    1. Wells WF. On air-borne infection: study II. Droplets and droplet nuclei. Am. J. Hyg. 1934;20:611–618.
    1. Goldmann DA. Epidemiology and prevention of pediatric viral respiratory infections in health-care institutions. Emerg. Infect. Dis. 2001;7:249–253. doi: 10.3201/eid0702.010220.
    1. Goldmann DA. Transmission of viral respiratory infections in the home. Pediatr. Infect. Dis. J. 2000;19:S97–S102. doi: 10.1097/00006454-200010001-00002.
    1. Gralton J, Tovey E, McLaws ML, Rawlinson WD. The role of particle size in aerosolised pathogen transmission: a review. J. Infect. 2011;62:1–13. doi: 10.1016/j.jinf.2010.11.010.
    1. Duguid JP. The size and the duration of air-carriage of respiratory droplets and droplet-nuclei. J. Hyg. 1946;44:471–479.
    1. Hatch, T. F. Behavior of microscopic particles in the air and in the respiratory system in Aerobiology (ed. Forest R. Moulton) 102–105 (American Association for the Advancement of Science, 1942).
    1. Hinds, W. C. Aerosol Technology: Properties, Behavior, and Measurement of Airborne Particles (John Wiley & Sons, 2012).
    1. Nicas M, Jones RM. Relative contributions of four exposure pathways to influenza infection risk. Risk Anal. 2009;29:1292–1303. doi: 10.1111/j.1539-6924.2009.01253.x.
    1. Roy CJ, Milton DK. Airborne transmission of communicable infection - The elusive pathway. N. Engl. J. Med. 2004;350:1710–1712. doi: 10.1056/NEJMp048051.
    1. Knight V. Viruses as agents of airborne contagion. Ann. N. Y. Acad. Sci. 1980;353:147–156. doi: 10.1111/j.1749-6632.1980.tb18917.x.
    1. National Academies of Sciences, Engineering, Medicine. Airborne Transmission of SARS-CoV-2: Proceedings of a Workshop — in Brief (eds Shelton-Davenport, M., Pavlin, J., Saunders, J. & Staudt, A.) (The National Academies Press, 2020).
    1. Bourouiba L. Turbulent gas clouds and respiratory pathogen emissions: potential implications for reducing transmission of COVID-19. JAMA. 2020;323:1838–1838.
    1. Lu J, et al. COVID-19 outbreak associated with air conditioning in restaurant, Guangzhou, China, 2020. Emerg. Infect. Dis. 2020;26:1628–1631. doi: 10.3201/eid2607.200764.
    1. Leung NH, et al. Quantification of influenza virus RNA in aerosols in patient rooms. PLoS ONE. 2016;11:e0148669. doi: 10.1371/journal.pone.0148669.
    1. Bischoff WE, Swett K, Leng I, Peters TR. Exposure to influenza virus aerosols during routine patient care. J. Infect. Dis. 2013;207:1037–1046. doi: 10.1093/infdis/jis773.
    1. Bloch AB, et al. Measles outbreak in a pediatric practice: airborne transmission in an office setting. Pediatrics. 1985;75:676–683. doi: 10.1542/peds.75.4.676.
    1. Remington PL, Hall WN, Davis IH, Herald A, Gunn RA. Airborne transmission of measles in a physician’s office. JAMA. 1985;253:1574–1577. doi: 10.1001/jama.1985.03350350068022.
    1. Yu IT, et al. Evidence of airborne transmission of the severe acute respiratory syndrome virus. N. Engl. J. Med. 2004;350:1731–1739. doi: 10.1056/NEJMoa032867.
    1. Sawyer MH, Chamberlin CJ, Wu YN, Aintablian N, Wallace MR. Detection of varicella-zoster virus DNA in air samples from hospital rooms. J. Infect. Dis. 1994;169:91–94. doi: 10.1093/infdis/169.1.91.
    1. Xiao S, Li Y, Sung M, Wei J, Yang Z. A study of the probable transmission routes of MERS-CoV during the first hospital outbreak in the Republic of Korea. Indoor Air. 2018;28:51–63. doi: 10.1111/ina.12430.
    1. Fennelly KP. Particle sizes of infectious aerosols: implications for infection control. Lancet Respir. Med. 2020;8:P914–924. doi: 10.1016/S2213-2600(20)30323-4.
    1. Couch RB, Cate TR, Douglas RG, Gerone PJ, Knight V. Effect of route of inoculation on experimental respiratory viral disease in volunteers and evidence for airborne transmission. Bacteriol. Rev. 1966;30:517–529. doi: 10.1128/br.30.3.517-529.1966.
    1. Alford RH, Kasel JA, Gerone PJ, Knight V. Human influenza resulting from aerosol inhalation. Proc. Soc. Exp. Biol. Med. 1966;122:800–804. doi: 10.3181/00379727-122-31255.
    1. Henle W, Henle G, Stokes J, Jr., Maris EP. Experimental exposure of human subjects to viruses of influenza. J. Immunol. 1946;52:145–165. doi: 10.4049/jimmunol.52.2.145.
    1. Teunis PF, Brienen N, Kretzschmar ME. High infectivity and pathogenicity of influenza A virus via aerosol and droplet transmission. Epidemics. 2010;2:215–222. doi: 10.1016/j.epidem.2010.10.001.
    1. Varble A, et al. Influenza A virus transmission bottlenecks are defined by infection route and recipient host. Cell Host Microbe. 2014;16:691–700. doi: 10.1016/j.chom.2014.09.020.
    1. Frise R, et al. Contact transmission of influenza virus between ferrets imposes a looser bottleneck than respiratory droplet transmission allowing propagation of antiviral resistance. Sci. Rep. 2016;6:29796. doi: 10.1038/srep29793.
    1. Spicknall IH, et al. Informing optimal environmental influenza interventions: how the host, agent, and environment alter dominant routes of transmission. PLoS Comput. Biol. 2010;6:e1000969. doi: 10.1371/journal.pcbi.1000969.
    1. Minhaz Ud-Dean SM. Structural explanation for the effect of humidity on persistence of airborne virus: seasonality of influenza. J. Theor. Biol. 2010;264:822–829. doi: 10.1016/j.jtbi.2010.03.013.
    1. Ausar SF, et al. Analysis of the thermal and pH stability of human respiratory syncytial virus. Mol. Pharm. 2005;2:491–499. doi: 10.1021/mp0500465.
    1. Ijaz MK, Brunner AH, Sattar SA, Nair RC, Johnson-Lussenburg CM. Survival characteristics of airborne human coronavirus 229E. J. Gen. Virol. 1985;66:2743–2748. doi: 10.1099/0022-1317-66-12-2743.
    1. Bajimaya S, Frankl T, Hayashi T, Takimoto T. Cholesterol is required for stability and infectivity of influenza A and respiratory syncytial viruses. Virology. 2017;510:234–241. doi: 10.1016/j.virol.2017.07.024.
    1. Mateu MG. Assembly, stability and dynamics of virus capsids. Arch. Biochem. Biophys. 2013;531:65–79. doi: 10.1016/j.abb.2012.10.015.
    1. Saha B, Wong CM, Parks RJ. The adenovirus genome contributes to the structural stability of the virion. Viruses. 2014;6:3563–3583. doi: 10.3390/v6093563.
    1. Gerba CP, Betancourt WQ. Viral aggregation: impact on virus behavior in the environment. Environ. Sci. Technol. 2017;51:7318–7325. doi: 10.1021/acs.est.6b05835.
    1. Bauer DW, et al. Exploring the balance between DNA pressure and capsid stability in herpesviruses and phages. J. Virol. 2015;89:9288–9298. doi: 10.1128/JVI.01172-15.
    1. Poon LL, et al. Quantifying influenza virus diversity and transmission in humans. Nat. Genet. 2016;48:195–200. doi: 10.1038/ng.3479.
    1. Russell CA, et al. The potential for respiratory droplet-transmissible A/H5N1 influenza virus to evolve in a mammalian host. Science. 2012;336:1541–1547. doi: 10.1126/science.1222526.
    1. Van Hoeven N, et al. Human HA and polymerase subunit PB2 proteins confer transmission of an avian influenza virus through the air. Proc. Natl Acad. Sci. USA. 2009;106:3366–3371. doi: 10.1073/pnas.0813172106.
    1. Schrauwen EJ, Fouchier RA. Host adaptation and transmission of influenza A viruses in mammals. Emerg. Microbes Infect. 2014;3:e9. doi: 10.1038/emi.2014.9.
    1. Gao Y, et al. Identification of amino acids in HA and PB2 critical for the transmission of H5N1 avian influenza viruses in a mammalian host. PLoS Pathog. 2009;5:e1000709. doi: 10.1371/journal.ppat.1000709.
    1. Pica N, Bouvier NM. Environmental factors affecting the transmission of respiratory viruses. Curr. Opin. Virol. 2012;2:90–95. doi: 10.1016/j.coviro.2011.12.003.
    1. Weber TP, Stilianakis NI. Inactivation of influenza A viruses in the environment and modes of transmission: a critical review. J. Infect. 2008;57:361–373. doi: 10.1016/j.jinf.2008.08.013.
    1. Sattar SA, et al. Activity of an alcohol-based hand gel against human adeno-, rhino-, and rotaviruses using the fingerpad method. Infect. Control. Hosp. Epidemiol. 2000;21:516–519. doi: 10.1086/501796.
    1. Luongo JC, et al. Role of mechanical ventilation in the airborne transmission of infectious agents in buildings. Indoor Air. 2016;26:666–678. doi: 10.1111/ina.12267.
    1. Sze-To GN, Yang Y, Kwan JK, Yu SC, Chao CY. Effects of surface material, ventilation, and human behavior on indirect contact transmission risk of respiratory infection. Risk Anal. 2014;34:818–830. doi: 10.1111/risa.12144.
    1. Lowen AC, Steel J, Mubareka S, Palese P. High temperature (30 degrees C) blocks aerosol but not contact transmission of influenza virus. J. Virol. 2008;82:5650–5652. doi: 10.1128/JVI.00325-08.
    1. Tamerius JD, et al. Environmental predictors of seasonal influenza epidemics across temperate and tropical climates. PLoS Pathog. 2013;9:e1003194. doi: 10.1371/journal.ppat.1003194.
    1. Moriyama M, Hugentobler WJ, Iwasaki A. Seasonality of respiratory viral infections. Annu. Rev. Virol. 2020;7:83–101. doi: 10.1146/annurev-virology-012420-022445.
    1. Hui KPY, et al. Tropism, replication competence, and innate immune responses of the coronavirus SARS-CoV-2 in human respiratory tract and conjunctiva: an analysis in ex-vivo and in-vitro cultures. Lancet Respir. Med. 2020;8:687–695. doi: 10.1016/S2213-2600(20)30193-4.
    1. Tsang TK, et al. Influenza a virus shedding and infectivity in households. J. Infect. Dis. 2015;212:1420–1428. doi: 10.1093/infdis/jiv225.
    1. Leung NHL, et al. Respiratory virus shedding in exhaled breath and efficacy of face masks. Nat. Med. 2020;26:676–680. doi: 10.1038/s41591-020-0843-2.
    1. Schwarz K, Biller H, Windt H, Koch W, Hohlfeld JM. Characterization of exhaled particles from the healthy human lung–a systematic analysis in relation to pulmonary function variables. J. Aerosol Med. Pulm. Drug Deliv. 2010;23:371–379. doi: 10.1089/jamp.2009.0809.
    1. He X, et al. Temporal dynamics in viral shedding and transmissibility of COVID-19. Nat. Med. 2020;26:672–675. doi: 10.1038/s41591-020-0869-5.
    1. Cevik M, et al. SARS-CoV-2, SARS-CoV, and MERS-CoV viral load dynamics, duration of viral shedding, and infectiousness: a systematic review and meta-analysis. Lancet Microbe. 2020;2:E12–E22.
    1. Byambasuren O, et al. Estimating the extent of asymptomatic COVID-19 and its potential for community transmission: systematic review and meta-analysis. J. Assoc. Med. Microbiol. Infect. Dis. Can. 2020 doi: 10.1101/2020.05.10.20097543.
    1. Maier HE, et al. Pre-existing anti-neuraminidase antibodies are associated with shortened duration of influenza A (H1N1)pdm virus shedding and illness in naturally infected adults. Clin. Infect. Dis. 2019;70:2290–2297. doi: 10.1093/cid/ciz639.
    1. Yan J, et al. Infectious virus in exhaled breath of symptomatic seasonal influenza cases from a college community. Proc. Natl Acad. Sci. USA. 2018;115:1081–1086. doi: 10.1073/pnas.1716561115.
    1. Hou YJ, et al. SARS-CoV-2 reverse genetics reveals a variable infection gradient in the respiratory tract. Cell. 2020;182:429–446.e14. doi: 10.1016/j.cell.2020.05.042.
    1. Long JS, Mistry B, Haslam SM, Barclay WS. Host and viral determinants of influenza A virus species specificity. Nat. Rev. Microbiol. 2018;17:67–81. doi: 10.1038/s41579-018-0115-z.
    1. Smith, H. Human Respiratory Tract Model for Radiological Protection. Report No. 66, (The International Commission on Radiological Protection, 1994).
    1. Horby P, Nguyen NY, Dunstan SJ, Baillie JK. An updated systematic review of the role of host genetics in susceptibility to influenza. Influenza Other Respir. Viruses. 2013;7(Suppl. 2):37–41. doi: 10.1111/irv.12079.
    1. Mossong J, et al. Social contacts and mixing patterns relevant to the spread of infectious diseases. PLoS Med. 2008;5:e74. doi: 10.1371/journal.pmed.0050074.
    1. Boone SA, Gerba CP. Significance of fomites in the spread of respiratory and enteric viral disease. Appl. Environ. Microbiol. 2007;73:1687–1696. doi: 10.1128/AEM.02051-06.
    1. Otter JA, et al. Transmission of SARS and MERS coronaviruses and influenza virus in healthcare settings: the possible role of dry surface contamination. J. Hosp. Infect. 2016;92:235–250. doi: 10.1016/j.jhin.2015.08.027.
    1. Ikonen N, et al. Deposition of respiratory virus pathogens on frequently touched surfaces at airports. BMC Infect. Dis. 2018;18:437. doi: 10.1186/s12879-018-3150-5.
    1. Mubareka S, et al. Transmission of influenza virus via aerosols and fomites in the guinea pig model. J. Infect. Dis. 2009;199:858–865. doi: 10.1086/597073.
    1. Gwaltney JM, Hendley JO. Transmission of experimental rhinovirus infection by contaminated surfaces. Am. J. Epidemiol. 1982;116:828–833. doi: 10.1093/oxfordjournals.aje.a113473.
    1. Barker J, Stevens D, Bloomfield SF. Spread and prevention of some common viral infections in community facilities and domestic homes. J. Appl. Microbiol. 2001;91:7–21. doi: 10.1046/j.1365-2672.2001.01364.x.
    1. Hall CB. Respiratory syncytial virus: its transmission in the hospital environment. Yale J. Biol. Med. 1982;55:219–223.
    1. Heung LC, Li T, Mak SK, Chan WM. Prevalence of subclinical infection and transmission of severe acute respiratory syndrome (SARS) in a residential care home for the elderly. Hong. Kong Med. J. 2006;12:201–207.
    1. Morawska L, et al. Size distribution and sites of origin of droplets expelled from the human respiratory tract during expiratory activities. J. Aerosol Sci. 2009;40:256–269. doi: 10.1016/j.jaerosci.2008.11.002.
    1. Fabian P, Brain J, Houseman EA, Gern J, Milton DK. Origin of exhaled breath particles from healthy and human rhinovirus-infected subjects. J. Aerosol Med. Pulm. Drug Deliv. 2011;24:137–147. doi: 10.1089/jamp.2010.0815.
    1. Gralton J, Tovey ER, McLaws ML, Rawlinson WD. Respiratory virus RNA is detectable in airborne and droplet particles. J. Med. Virol. 2013;85:2151–2159. doi: 10.1002/jmv.23698.
    1. Milton DK, Fabian MP, Cowling BJ, Grantham ML, McDevitt JJ. Influenza virus aerosols in human exhaled breath: particle size, culturability, and effect of surgical masks. PLoS Pathog. 2013;9:e1003205. doi: 10.1371/journal.ppat.1003205.
    1. Dick EC, Jennings LC, Mink KA, Wartgow CD, Inhorn SL. Aerosol transmission of rhinovirus colds. J. Infect. Dis. 1987;156:442–448. doi: 10.1093/infdis/156.3.442.
    1. Olsen SJ, et al. Transmission of the severe acute respiratory syndrome on aircraft. N. Engl. J. Med. 2003;349:2416–2422. doi: 10.1056/NEJMoa031349.
    1. Andrewes C, Glover R. Spread of infection from the respiratory tract of the ferret. I. Transmission of influenza A virus. Br. J. Exp. Pathol. 1941;22:91.
    1. Sia SF, et al. Pathogenesis and transmission of SARS-CoV-2 in golden hamsters. Nature. 2020;583:834–838. doi: 10.1038/s41586-020-2342-5.
    1. Moser MR, et al. An outbreak of influenza aboard a commercial airliner. Am. J. Epidemiol. 1979;110:1–6. doi: 10.1093/oxfordjournals.aje.a112781.
    1. Myatt TA, et al. Detection of airborne rhinovirus and its relation to outdoor air supply in office environments. Am. J. Respir. Crit. Care Med. 2004;169:1187–1190. doi: 10.1164/rccm.200306-760OC.
    1. Offeddu V, Yung CF, Low MSF, Tam CC. Effectiveness of masks and respirators against respiratory infections in healthcare workers: a systematic review and meta-analysis. Clin. Infect. Dis. 2017;65:1934–1942. doi: 10.1093/cid/cix681.
    1. Jordan WS., Jr. The mechanism of spread of Asian influenza. Am. Rev. Respir. Dis. 1961;83:29–40.
    1. Cowling BJ, et al. Facemasks and hand hygiene to prevent influenza transmission in households: a cluster randomized trial. Ann. Intern. Med. 2009;151:437–446. doi: 10.7326/0003-4819-151-7-200910060-00142.
    1. Killingley B, et al. Use of a human influenza challenge model to assess person-to-person transmission: proof-of-concept study. J. Infect. Dis. 2012;205:35–43. doi: 10.1093/infdis/jir701.
    1. Azimi P, Keshavarz Z, Cedeno Laurent JG, Stephens B, Allen JG. Mechanistic transmission modeling of COVID-19 on the Diamond Princess cruise ship demonstrates the importance of aerosol transmission. Proc. Natl Acad. Sci. USA. 2021;118:e2015482118. doi: 10.1073/pnas.2015482118.
    1. Jones RM. Relative contributions of transmission routes for COVID-19 among healthcare personnel providing patient care. J. Occup. Environ. Hyg. 2020;17:408–415. doi: 10.1080/15459624.2020.1784427.
    1. Atkinson MP, Wein LM. Quantifying the routes of transmission for pandemic influenza. Bull. Math. Biol. 2008;70:820–867. doi: 10.1007/s11538-007-9281-2.
    1. Jones RM, Adida E. Influenza infection risk and predominate exposure route: uncertainty analysis. Risk Anal. 2011;31:1622–1631. doi: 10.1111/j.1539-6924.2011.01600.x.
    1. World Health Organization. Infection prevention and control of epidemic-and pandemic prone acute respiratory infections in health care - WHO guidelines. (2014).
    1. Morawska L, Milton DK. It is time to address airborne transmission of COVID-19. Clin. Infect. Dis. 2020;71:2311–2312.
    1. World Health Organization. Report of the WHO-China Joint Mission on Coronavirus Disease 2019 (COVID-19). (2020).
    1. van Doremalen N, et al. Aerosol and surface stability of SARS-CoV-2 as compared with SARS-CoV-1. N. Engl. J. Med. 2020;382:1564–1567. doi: 10.1056/NEJMc2004973.
    1. Cheng VCC, et al. Escalating infection control response to the rapidly evolving epidemiology of the coronavirus disease 2019 (COVID-19) due to SARS-CoV-2 in Hong Kong. Infect. Control. Hosp. Epidemiol. 2020;41:493–498. doi: 10.1017/ice.2020.58.
    1. Ong SWX, et al. Air, surface environmental, and personal protective equipment contamination by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) from a symptomatic patient. JAMA. 2020;323:1610–1612. doi: 10.1001/jama.2020.3227.
    1. Somsen GA, van Rijn C, Kooij S, Bem RA, Bonn D. Small droplet aerosols in poorly ventilated spaces and SARS-CoV-2 transmission. Lancet Respir. Med. 2020;8:658–659. doi: 10.1016/S2213-2600(20)30245-9.
    1. Lindsley WG, et al. Viable influenza a virus in airborne particles from human coughs. J. Occup. Environ. Hyg. 2015;12:107–113. doi: 10.1080/15459624.2014.973113.
    1. Xie X, Li Y, Chwang AT, Ho PL, Seto WH. How far droplets can move in indoor environments–revisiting the Wells evaporation-falling curve. Indoor Air. 2007;17:211–225. doi: 10.1111/j.1600-0668.2007.00469.x.
    1. Liu Y, et al. Aerodynamic analysis of SARS-CoV-2 in two Wuhan hospitals. Nature. 2020;582:557–560. doi: 10.1038/s41586-020-2271-3.
    1. Kulkarni H, et al. Evidence of respiratory syncytial virus spread by aerosol. time to revisit infection control strategies? Am. J. Respir. Crit. Care Med. 2016;194:308–316. doi: 10.1164/rccm.201509-1833OC.
    1. Kim SH, et al. Extensive viable Middle East respiratory syndrome (MERS) coronavirus contamination in air and surrounding environment in MERS isolation wards. Clin. Infect. Dis. 2016;63:363–369. doi: 10.1093/cid/ciw239.
    1. Lednicky JA, et al. Viable SARS-CoV-2 in the air of a hospital room with COVID-19 patients. Int. J. Infect. Dis. 2020;100:476–482. doi: 10.1016/j.ijid.2020.09.025.
    1. Buonanno G, Morawska L, Stabile L. Quantitative assessment of the risk of airborne transmission of SARS-CoV-2 infection: Prospective and retrospective applications. Environ. Int. 2020;145:106112. doi: 10.1016/j.envint.2020.106112.
    1. Cai J, et al. Indirect virus transmission in cluster of COVID-19 cases, Wenzhou, China, 2020. Emerg. Infect. Dis. 2020;26:1343–1345. doi: 10.3201/eid2606.200412.
    1. Miller SL, et al. Transmission of SARS-CoV-2 by inhalation of respiratory aerosol in the Skagit Valley Chorale superspreading event. Indoor Air. 2020 doi: 10.1111/ina.12751.
    1. Hamner L, et al. High SARS-CoV-2 attack rate following exposure at a choir practice - Skagit County, Washington, March 2020. MMWR. 2020;69:606–610.
    1. Li, Y. et al. Evidence for probable aerosol transmission of SARS-CoV-2 in a poorly ventilated restaurant. Build. Environ.10.1016/j.buildenv.2021.107788 (2021).
    1. Thomas BR. Does expert opinion trump evidence? Clin. Infect. Dis. 2020 doi: 10.1093/cid/ciaa1115.
    1. Chagla Z, Hota S, Khan S, Mertz D. Re: it is time to address airborne transmission of COVID-19. Clin. Infect. Dis. 2020 doi: 10.1093/cid/ciaa1118.
    1. Morawska L, Milton DK. Reply to Chagla et al., and Thomas. Clin. Infect. Dis. 2020 doi: 10.1093/cid/ciaa1121.
    1. Ma, J. et al. Coronavirus disease 2019 patients in earlier stages exhaled millions of severe acute respiratory syndrome coronavirus 2 Per Hour. Clin. Infect. Dis.10.1093/cid/ciaa1283 (2020).
    1. Chia PY, et al. Detection of air and surface contamination by SARS-CoV-2 in hospital rooms of infected patients. Nat. Commun. 2020;11:2800. doi: 10.1038/s41467-020-16670-2.
    1. Guo ZD, et al. Aerosol and surface distribution of severe acute respiratory syndrome coronavirus 2 in hospital wards, Wuhan, China, 2020. Emerg. Infect. Dis. 2020;26:1583–1591. doi: 10.3201/eid2607.200885.
    1. Barclay WS, et al. Investigating SARS-CoV-2 surface and air contamination in an acute healthcare setting during the peak of the COVID-19 pandemic in London. Clin. Infect. Dis. 2020 doi: 10.1093/cid/ciaa905.
    1. Santarpia JL, et al. Aerosol and surface contamination of SARS-CoV-2 observed in quarantine and isolation care. Sci. Rep. 2020;10:12732. doi: 10.1038/s41598-020-69286-3.
    1. Bullard J, et al. Predicting infectious SARS-CoV-2 from diagnostic samples. Clin. Infect. Dis. 2020 doi: 10.1093/cid/ciaa638.
    1. Jang S, Han SH, Rhee JY. Cluster of coronavirus disease associated with fitness dance classes, South Korea. Emerg. Infect. Dis. 2020;26:1917–1920. doi: 10.3201/eid2608.200633.
    1. Leclerc Q, et al. What settings have been linked to SARS-CoV-2 transmission clusters? [version 1; peer review: 1 approved with reservations] Wellcome Open Res. 2020 doi: 10.12688/wellcomeopenres.15889.2.
    1. Tellier R. Review of aerosol transmission of influenza A virus. Emerg. Infect. Dis. 2006;12:1657–1662. doi: 10.3201/eid1211.060426.
    1. Xie C, et al. Detection of influenza and other respiratory viruses in air sampled from a university campus: a longitudinal study. Clin. Infect. Dis. 2019;70:580–858.
    1. Wong BC, et al. Possible role of aerosol transmission in a hospital outbreak of influenza. Clin. Infect. Dis. 2010;51:1176–1183. doi: 10.1086/656743.
    1. Wells WF, Brown HW. Recovery of influenza virus suspended in air. Science. 1936;84:68–69. doi: 10.1126/science.84.2168.68-b.
    1. Coleman KK, et al. Bioaerosol sampling for respiratory viruses in Singapore’s mass rapid transit network. Sci. Rep. 2018;8:17476. doi: 10.1038/s41598-018-35896-1.
    1. Lindsley WG, et al. Distribution of airborne influenza virus and respiratory syncytial virus in an urgent care medical clinic. Clin. Infect. Dis. 2010;50:693–698.
    1. Leclair JM, Zaia JA, Levin MJ, Congdon RG, Goldmann DA. Airborne transmission of chickenpox in a hospital. N. Engl. J. Med. 1980;302:450–453. doi: 10.1056/NEJM198002213020807.
    1. Thomson F. The aerial conveyance of infection. Lancet. 1914;183:1669–1673. doi: 10.1016/S0140-6736(01)58406-8.
    1. Riley RL, et al. Aerial dissemination of pulmonary tuberculosis. A two-year study of contagion in a tuberculosis ward. Am. J. Hyg. 1959;70:185–196.
    1. Wong TW, et al. Cluster of SARS among medical students exposed to single patient, Hong Kong. Emerg. Infect. Dis. 2004;10:269–276. doi: 10.3201/eid1002.030452.
    1. Liu L, Li Y, Nielsen PV, Wei J, Jensen RL. Short-range airborne transmission of expiratory droplets between two people. Indoor Air. 2017;27:452–462. doi: 10.1111/ina.12314.
    1. World Health Organization. Epidemic-prone and pandemic-prone acute respiratory diseases. Summary guidance: Infection prevention & control in health-care facilities. (2007).
    1. World Health Organization. WHO Guidelines on Hand Hygiene in Health Care (World Health Organization, 2009).
    1. Suchomel M, Steinmann J, Kampf G. Efficacies of the original and modified WHO-recommended hand rub formulations. J. Hosp. Infect. 2020;106:264–270. doi: 10.1016/j.jhin.2020.08.006.
    1. Cowling BJ, et al. Aerosol transmission is an important mode of influenza A virus spread. Nat. Commun. 2013;4:1935. doi: 10.1038/ncomms2922.
    1. World Health Organization. Infection prevention and control during health care when novel coronavirus (nCoV) infection is suspected: interim guidance (March 2020). (2020).
    1. World Health Organization. Advice on the use of masks in the context of COVID-19: Interim guidance (5 June 2020). Report no. WHO/2019-nCov/IPC_Masks/2020.4 (World Health Organization, 2020).
    1. Kwok YLA, Gralton J, McLaws M-L. Face touching: a frequent habit that has implications for hand hygiene. Am. J. Infect. Control. 2015;43:112–114. doi: 10.1016/j.ajic.2014.10.015.
    1. Diaz KT, Smaldone GC. Quantifying exposure risk: surgical masks and respirators. Am. J. Infect. Control. 2010;38:501–508. doi: 10.1016/j.ajic.2010.06.002.
    1. Ueki H, et al. Effectiveness of face masks in preventing airborne transmission of SARS-CoV-2. mSphere. 2020 doi: 10.1128/mSphere.00637-20.
    1. Chu DK, et al. Physical distancing, face masks, and eye protection to prevent person-to-person transmission of SARS-CoV-2 and COVID-19: a systematic review and meta-analysis. Lancet. 2020;395:1973–1987. doi: 10.1016/S0140-6736(20)31142-9.
    1. Bakhit M, et al. Downsides of face masks and possible mitigation strategies: a systematic review and meta-analysis. BMJ Open. 2021 doi: 10.1101/2020.06.16.20133207.
    1. Kampf G, Todt D, Pfaender S, Steinmann E. Persistence of coronaviruses on inanimate surfaces and their inactivation with biocidal agents. J. Hosp. Infect. 2020;104:246–251. doi: 10.1016/j.jhin.2020.01.022.
    1. Greatorex JS, et al. Effectiveness of common household cleaning agents in reducing the viability of human influenza A/H1N1. PLoS ONE. 2010;5:e8987. doi: 10.1371/journal.pone.0008987.
    1. Wei J, Li Y. Airborne spread of infectious agents in the indoor environment. Am. J. Infect. Control. 2016;44:S102–S108. doi: 10.1016/j.ajic.2016.06.003.
    1. Ibfelt T, Engelund EH, Schultz AC, Andersen LP. Effect of cleaning and disinfection of toys on infectious diseases and micro-organisms in daycare nurseries. J. Hosp. Infect. 2015;89:109–115. doi: 10.1016/j.jhin.2014.10.007.
    1. Atkinson, J. et al. Natural ventilation for infection control in health-care settings: WHO guidelines 2009. (2009).
    1. Sehulster, L. M. et al. Guidelines for Environmental Infection Control in Health-Care Facilities. Recommendations of CDC and the Healthcare Infection Control Practices Advisory Committee (HICPAC). (2004).
    1. Sundell J, et al. Ventilation rates and health: multidisciplinary review of the scientific literature. Indoor Air. 2011;21:191–204. doi: 10.1111/j.1600-0668.2010.00703.x.
    1. Chen C, Zhao B, Yang X, Li Y. Role of two-way airflow owing to temperature difference in severe acute respiratory syndrome transmission: revisiting the largest nosocomial severe acute respiratory syndrome outbreak in Hong Kong. J. R. Soc. Interface. 2011;8:699–710. doi: 10.1098/rsif.2010.0486.
    1. Sze To GN, Wan MP, Chao CYH, Fang L, Melikov A. Experimental study of dispersion and deposition of expiratory aerosols in aircraft cabins and impact on infectious disease transmission. Aerosol Sci. Technol. 2009;43:466–485. doi: 10.1080/02786820902736658.
    1. Nardell EA, Keegan J, Cheney SA, Etkind SC. Airborne infection. Theoretical limits of protection achievable by building ventilation. Am. Rev. Respir. Dis. 1991;144:302–306. doi: 10.1164/ajrccm/144.2.302.
    1. Memarzadeh F, Xu W. Role of air changes per hour (ACH) in possible transmission of airborne infections. Build. Simul. 2012;5:15–28. doi: 10.1007/s12273-011-0053-4.
    1. Nardell EA, Nathavitharana RR. Airborne spread of SARS-CoV-2 and a potential role for air disinfection. JAMA. 2020;324:141–142. doi: 10.1001/jama.2020.7603.
    1. Centers for Disease Control and Prevention. Environmental Control for Tuberculosis: Basic Upper-Room Ultraviolet Germicidal Irradiation Guidelines for Healthcare Settings. (2009).
    1. Reed NG. The History of ultraviolet germicidal irradiation for air disinfection. Public. Health Rep. 2010;125:15–27. doi: 10.1177/003335491012500105.
    1. Wells WF, Wells MW, Wilder TS. The environmental control of epidemic contagion: I. An epidemiologic study of radiant disinfection of air in day schools. Am. J. Epidemiol. 1942;35:97–121. doi: 10.1093/oxfordjournals.aje.a118789.
    1. Dancer SJ. Controlling hospital-acquired infection: focus on the role of the environment and new technologies for decontamination. Clin. Microbiol. Rev. 2014;27:665–690. doi: 10.1128/CMR.00020-14.
    1. Bedell K, Buchaklian AH, Perlman S. Efficacy of an automated multiple emitter whole-room ultraviolet-C disinfection system against coronaviruses MHV and MERS-CoV. Infect. Control. Hosp. Epidemiol. 2016;37:598–599. doi: 10.1017/ice.2015.348.
    1. Mills D, Harnish DA, Lawrence C, Sandoval-Powers M, Heimbuch BK. Ultraviolet germicidal irradiation of influenza-contaminated N95 filtering facepiece respirators. Am. J. Infect. Control. 2018;46:e49–e55. doi: 10.1016/j.ajic.2018.02.018.
    1. Seresirikachorn K, et al. Decontamination and reuse of surgical masks and N95 filtering facepiece respirators during the COVID-19 pandemic: a systematic review. Infect. Control. Hosp. Epidemiol. 2020;42:25–30. doi: 10.1017/ice.2020.379.
    1. International Commission on Illumination. CIE position statement on ultraviolet (UV) radiation to manage the risk of COVID-19 transmission. (2020).
    1. Gwaltney JM, Jr., Moskalski PB, Hendley JO. Interruption of experimental rhinovirus transmission. J. Infect. Dis. 1980;142:811–815. doi: 10.1093/infdis/142.6.811.
    1. Wong VW, Cowling BJ, Aiello AE. Hand hygiene and risk of influenza virus infections in the community: a systematic review and meta-analysis. Epidemiol. Infect. 2014;142:922–932. doi: 10.1017/S095026881400003X.
    1. Thangavel RR, Bouvier NM. Animal models for influenza virus pathogenesis, transmission, and immunology. J. Immunol. Methods. 2014;410:60–79. doi: 10.1016/j.jim.2014.03.023.
    1. Lowen AC, Mubareka S, Tumpey TM, Garcia-Sastre A, Palese P. The guinea pig as a transmission model for human influenza viruses. Proc. Natl Acad. Sci. USA. 2006;103:9988–9992. doi: 10.1073/pnas.0604157103.
    1. Sutton TC, Subbarao K. Development of animal models against emerging coronaviruses: from SARS to MERS coronavirus. Virology. 2015;479-480:247–258. doi: 10.1016/j.virol.2015.02.030.
    1. Lakdawala SS, Menachery VD. The search for a COVID-19 animal model. Science. 2020;368:942–943. doi: 10.1126/science.abc6141.
    1. McCray PB, Jr., et al. Lethal infection of K18-hACE2 mice infected with severe acute respiratory syndrome coronavirus. J. Virol. 2007;81:813–821. doi: 10.1128/JVI.02012-06.
    1. Nishiura H, Yen HL, Cowling BJ. Sample size considerations for one-to-one animal transmission studies of the influenza A viruses. PLoS ONE. 2013;8:e55358. doi: 10.1371/journal.pone.0055358.
    1. Belser JA, Maines TR, Katz JM, Tumpey TM. Considerations regarding appropriate sample size for conducting ferret transmission experiments. Future Microbiol. 2013;8:961–965. doi: 10.2217/fmb.13.64.
    1. Delamater PL, Street EJ, Leslie TF, Yang YT, Jacobsen KH. Complexity of the basic reproduction number (R0) Emerg. Infect. Dis. 2019;25:1–4. doi: 10.3201/eid2501.171901.
    1. Reis J, Shaman J. Simulation of four respiratory viruses and inference of epidemiological parameters. Infect. Dis. Model. 2018;3:23–34.
    1. Spencer, J. et al. Epidemiological parameter review and comparative dynamics of influenza, respiratory syncytial virus, rhinovirus, human coronavirus, and adenovirus. Preprint at 10.1101/2020.02.04.20020404v1 (2020).
    1. Guo Z, et al. Epidemiological analysis of an outbreak of an adenovirus type 7 infection in a boot camp in China. PLoS ONE. 2020;15:e0232948. doi: 10.1371/journal.pone.0232948.
    1. Park M, Cook AR, Lim JT, Sun Y, Dickens BL. A systematic review of COVID-19 epidemiology based on current evidence. J. Clin. Med. 2020;9:967. doi: 10.3390/jcm9040967.
    1. Biggerstaff M, Cauchemez S, Reed C, Gambhir M, Finelli L. Estimates of the reproduction number for seasonal, pandemic, and zoonotic influenza: a systematic review of the literature. BMC Infect. Dis. 2014;14:480. doi: 10.1186/1471-2334-14-480.
    1. Nardone A, et al. The comparative sero-epidemiology of varicella zoster virus in 11 countries in the European region. Vaccine. 2007;25:7866–7872. doi: 10.1016/j.vaccine.2007.07.036.
    1. Guerra FM, et al. The basic reproduction number (R0) of measles: a systematic review. Lancet Infect. Dis. 2017;17:e420–e428. doi: 10.1016/S1473-3099(17)30307-9.
    1. Goeyvaerts N, et al. Estimating dynamic transmission model parameters for seasonal influenza by fitting to age and season-specific influenza-like illness incidence. Epidemics. 2015;13:1–9. doi: 10.1016/j.epidem.2015.04.002.
    1. Zhang J, et al. Changes in contact patterns shape the dynamics of the COVID-19 outbreak in China. Science. 2020;368:1481–1486. doi: 10.1126/science.abb8001.
    1. Kissler SM, Tedijanto C, Goldstein E, Grad YH, Lipsitch M. Projecting the transmission dynamics of SARS-CoV-2 through the postpandemic period. Science. 2020;368:860–868. doi: 10.1126/science.abb5793.
    1. Muller NF, et al. Characterising the epidemic spread of influenza A/H3N2 within a city through phylogenetics. PLoS Pathog. 2020;16:e1008984. doi: 10.1371/journal.ppat.1008984.
    1. Lemey P, et al. Unifying viral genetics and human transportation data to predict the global transmission dynamics of human influenza H3N2. PLoS Pathog. 2014;10:e1003932. doi: 10.1371/journal.ppat.1003932.
    1. van Dorp L, et al. No evidence for increased transmissibility from recurrent mutations in SARS-CoV-2. Nat. Commun. 2020;11:5986. doi: 10.1038/s41467-020-19818-2.
    1. Lloyd-Smith JO, Schreiber SJ, Kopp PE, Getz WM. Superspreading and the effect of individual variation on disease emergence. Nature. 2005;438:355–359. doi: 10.1038/nature04153.
    1. Adam DC, et al. Clustering and superspreading potential of SARS-CoV-2 infections in Hong Kong. Nat. Med. 2020;26:1714–1719. doi: 10.1038/s41591-020-1092-0.
    1. Riley S, et al. Transmission dynamics of the etiological agent of SARS in Hong Kong: Impact of public health interventions. Science. 2003;300:1961–1966. doi: 10.1126/science.1086478.
    1. Randolph HE, Barreiro LB. Herd immunity: understanding COVID-19. Immunity. 2020;52:737–741. doi: 10.1016/j.immuni.2020.04.012.
    1. Halloran, M. E. Secondary attack rate. In Encyclopedia of Biostatistics (eds Armitage, P. & Colton, T.) (Wiley, 2005).
    1. Tsang TK, Lau LL, Cauchemez S, Cowling BJ. Household transmission of influenza virus. Trends Microbiol. 2016;24:123–133. doi: 10.1016/j.tim.2015.10.012.
    1. Lau LL, et al. Household transmission of 2009 pandemic influenza A (H1N1): a systematic review and meta-analysis. Epidemiology. 2012;23:531–542. doi: 10.1097/EDE.0b013e31825588b8.
    1. Simpson RE. Infectiousness of communicable diseases in the household (measles, chickenpox, and mumps) Lancet. 1952;2:549–554. doi: 10.1016/S0140-6736(52)91357-3.
    1. Cowling BJ, et al. Comparative epidemiology of pandemic and seasonal influenza A in households. N. Engl. J. Med. 2010;362:2175–2184. doi: 10.1056/NEJMoa0911530.
    1. Leitmeyer K, Adlhoch C. Review article: influenza transmission on aircraft: a systematic literature review. Epidemiology. 2016;27:743–751. doi: 10.1097/EDE.0000000000000438.
    1. Klick B, Leung GM, Cowling BJ. Optimal design of studies of influenza transmission in households. I: case-ascertained studies. Epidemiol. Infect. 2012;140:106–114. doi: 10.1017/S0950268811000392.
    1. Leung NH, Xu C, Ip DK, Cowling BJ. Review article: the fraction of influenza virus infections that are asymptomatic: a systematic review and meta-analysis. Epidemiology. 2015;26:862–872. doi: 10.1097/EDE.0000000000000340.
    1. Cooney MK, Fox JP, Hall CE. The Seattle Virus Watch. VI. Observations of infections with and illness due to parainfluenza, mumps and respiratory syncytial viruses and Mycoplasma pneumoniae. Am. J. Epidemiol. 1975;101:532–551. doi: 10.1093/oxfordjournals.aje.a112125.
    1. Fox JP, Cooney MK, Hall CE. The Seattle Virus Watch. V. Epidemiologic observations of rhinovirus infections, 1965–1969, in families with young children. Am. J. Epidemiol. 1975;101:122–143. doi: 10.1093/oxfordjournals.aje.a112078.
    1. Hall CB, et al. Respiratory syncytial virus infections within families. N. Engl. J. Med. 1976;294:414–419. doi: 10.1056/NEJM197602192940803.
    1. Madewell ZJ, Yang Y, Longini IM, Jr., Halloran ME, Dean NE. Household transmission of SARS-CoV-2: a systematic review and meta-analysis. JAMA Netw. Open. 2020;3:e2031756. doi: 10.1001/jamanetworkopen.2020.31756.
    1. Banatvala JE, Anderson TB, Reiss BB. Parainfluenza infections in the community. BMJ. 1964;1:537–540. doi: 10.1136/bmj.1.5382.537.
    1. Seward JF, Zhang JX, Maupin TJ, Mascola L, Jumaan AO. Contagiousness of varicella in vaccinated cases: a household contact study. JAMA. 2004;292:704–708. doi: 10.1001/jama.292.6.704.
    1. Top FH. Measles in Detroit, 1935 — I, factors influencing the secondary attack rate among susceptibles at risk. Am. J. Public Health Nations Health. 1938;28:935–943. doi: 10.2105/AJPH.28.8.935.
    1. Zhang W, et al. Secondary transmission of coronavirus disease from presymptomatic persons, China. Emerg. Infect. Dis. 2020;26:1924–1926. doi: 10.3201/eid2608.201142.
    1. Cauchemez S, et al. Determinants of influenza transmission in South East Asia: insights from a household cohort study in Vietnam. PLoS Pathog. 2014;10:e1004310. doi: 10.1371/journal.ppat.1004310.
    1. Welliver R, et al. Effectiveness of oseltamivir in preventing influenza in household contacts: a randomized controlled trial. JAMA. 2001;285:748–754. doi: 10.1001/jama.285.6.748.
    1. McCormick JB, Halsey N, Rosenberg R. Measles vaccine efficacy determined from secondary attack rates during a severe epidemic. J. Pediatr. 1977;90:13–16. doi: 10.1016/S0022-3476(77)80756-7.
    1. Cauchemez S, et al. Household transmission of 2009 pandemic influenza A (H1N1) virus in the United States. N. Engl. J. Med. 2009;361:2619–2627. doi: 10.1056/NEJMoa0905498.
    1. Lau MS, Cowling BJ, Cook AR, Riley S. Inferring influenza dynamics and control in households. Proc. Natl Acad. Sci. USA. 2015;112:9094–9099. doi: 10.1073/pnas.1423339112.
    1. Wells W, Wells M. Air-borne infection. J. Am. Med. Assoc. 1936;107:1698–1703. doi: 10.1001/jama.1936.02770470016004.

Source: PubMed

Sponzoři a spolupracovníci

Zdravotní podmínky

Drogové intervence

3
Předplatit